Amylyx Pharmaceuticals Inc ( AMLX ) acquired avexitide from Eiger BioPharmaceuticals Inc ( EIGRQ ) for $35.1 million. Avexitide is an investigational, first-in-class glucagon-like peptide-1 (GLP-1) receptor antagonist that has been evaluated in five clinical trials for post-bariatric hypoglycemia (PBH) and has also been studied in congenital hyperinsulinism (HI), two indications characterized by hyperinsulinemic hypoglycemia. The FDA has granted avexitide...

03:17 PM EDT, 07/10/2024 (MT Newswires) -- Timbercreek Financial ( TBCRF ) , an alternative asset class investment manager, on Wednesday announced that Timbercreek Alternatives LP, a subsidiary of Timbercreek Capital, and Aspen Properties have entered into a joint venture to form 1 Palliser Square LP, which intends to complete a private placement offering of up to 3 million Series...

03:21 PM EDT, 07/10/2024 (MT Newswires) -- (Updates with additional details throughout.) The Federal Trade Commission plans to sue the three largest pharmacy-benefit managers, including OptumRx, Express Scripts, and CVS Caremark, over their drug pricing tactics, including insulin, the Wall Street Journal reported Wednesday. This follows a two-year investigation into whether these companies steered patients toward more-expensive medicines. These three...

03:31 PM EDT, 07/10/2024 (MT Newswires) -- Consumer stocks were higher late Wednesday afternoon, with the Consumer Staples Select Sector SPDR Fund (XLP) rising 0.3% and the Consumer Discretionary Select Sector SPDR Fund (XLY) up 0.7%. In corporate news, Ziff Davis ( ZD ) shares sank 11% after it disclosed plans to exchange about $401 million of its 1.75% convertible...